Elevation Oncology Inc (NAS:ELEV)
$ 3.84 0.15 (4.07%) Market Cap: 209.81 Mil Enterprise Value: 136.57 Mil PE Ratio: 0 PB Ratio: 2.62 GF Score: 21/100

Elevation Oncology Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2023 / 05:45PM GMT
Release Date Price: $1.03 (+11.96%)
Priyanka Grover
JPMorgan Chase & Co. - Analyst

Hi, everyone. Good morning. My name is Priyanka Grover, and welcome to the 41st Annual JPMorgan Healthcare Conference. I'm joined by senior analyst, Anupam Rama and fellow associate, Malcolm Kuno. Today, we'll be hearing from Elevation Oncology, followed by a Q&A session. And I'd like to present Interim CEO and CFO, Joe Ferra, who will present on behalf of Elevation Oncology. Thank you.

Joe Ferra
Elevation Oncology, Inc. - Interim CEO & CFO

Thank you, Priyanka. Thank you to the JPMorgan team. Thank you all for joining me today. I'm Joe Ferra, Interim Chief Executive Officer and Chief Financial Officer of Elevation Oncology. I look forward to telling you more about our company today and telling you more about our focus on making a difference for patients suffering from cancer.

Please note that during this presentation, I'll be making some forward-looking statements. For a complete review of our risk factors, I invite you to visit our website and also our SEC filings.

Today, I'm

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot